PULSE BIOSCIENCES, INC. — Director's Dealing 2017

Nov 6, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2017-11-02

Reporting Person: Clark Kenneth A (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-11-02	Stock Option (right to buy)	$23.08	A	65000	Acquired	2027-11-02	Common Stock (65000)	Direct

Footnotes

F1: One-third (1/3) of the shares subject to the option will vest on November 2, 2018, and the remaining shares will vest in equal monthly installments thereafter over the following two year period, subject to the Reporting Person's continued service through each vesting date.